ResMed Inc.
RMD
Rang in aandelen
#724
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Aandeelprijs
$239.50
Marktkapitalisatie
$33.68B
Verandering (1 dag)
0.43%
Verandering (1 jaar)
-10.66%
Land
US
Handel ResMed Inc. (RMD)
Categorie
Healthcare
EPS voor ResMed Inc. (RMD)
EPS per June 2026 TTM: $10.44
Volgens de laatste financiële rapporten en de aandelenkoers van ResMed Inc. is de huidige EPS van het bedrijf (TTM) $10.44. Eind 2024 had het bedrijf een EPS van $6.94, een stijging ten opzichte van de EPS van 2023 die $6.12 bedroeg.
EPS-geschiedenis van ResMed Inc. van 2000 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $10.44 | 9.32% |
| 2025 | $9.55 | 37.61% |
| 2024 | $6.94 | 13.40% |
| 2023 | $6.12 | 14.61% |
| 2022 | $5.34 | 63.30% |
| 2021 | $3.27 | -24.13% |
| 2020 | $4.31 | 52.30% |
| 2019 | $2.83 | 28.05% |
| 2018 | $2.21 | -8.68% |
| 2017 | $2.42 | -3.59% |
| 2016 | $2.51 | 0.00% |
| 2015 | $2.51 | 2.87% |
| 2014 | $2.44 | 13.49% |
| 2013 | $2.15 | 22.86% |
| 2012 | $1.75 | 17.45% |
| 2011 | $1.49 | 18.25% |
| 2010 | $1.26 | 29.90% |
| 2009 | $0.97 | 34.72% |
| 2008 | $0.72 | 67.44% |
| 2007 | $0.43 | -29.51% |
| 2006 | $0.61 | 29.79% |
| 2005 | $0.47 | 9.30% |
| 2004 | $0.43 | 22.86% |
| 2003 | $0.35 | 20.69% |
| 2002 | $0.29 | 213.51% |
| 2001 | $0.09 | -51.32% |
| 2000 | $0.19 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $3.11 | -70.21% |
US
|
|
| $3.59 | -65.61% |
IE
|
|
| $9.73 | -6.80% |
US
|
|
| $2.48 | -76.25% |
US
|
|
| - | - |
DE
|
